Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial

AIMS: We compared patient-reported treatment satisfaction and the economic impact of anticoagulation therapy with rivaroxaban vs. vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation undergoing elective cardioversion procedures. METHODS AND RESULTS: The current study is a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohnloser, Stefan H., Cappato, Riccardo, Ezekowitz, Michael D., Evers, Thomas, Sahin, Kurtulus, Kirchhof, Paulus, Meng, Isabelle Ling, van Eickels, Martin, Camm, A. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767121/
https://www.ncbi.nlm.nih.gov/pubmed/26487668
http://dx.doi.org/10.1093/europace/euv294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767121/
https://www.ncbi.nlm.nih.gov/pubmed/26487668
http://dx.doi.org/10.1093/europace/euv294

Ejemplares similares